KOMB:PSECZKomercni banka, a.s. Analysis
Data as of 2026-03-11 - not real-time
CZK 1,129.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Komercní banka trades at 1,129 CZK, which sits below its 20‑day (1,164.65) and 50‑day (1,200.56) simple moving averages but remains above the 200‑day SMA (1,098.20), signaling a neutral to slightly bearish short‑term bias. The RSI of 36.8 hints at oversold conditions, while the MACD line is under the signal line, reinforcing a bearish momentum outlook. The stock finds technical support near 1,111 CZK and faces resistance around 1,229 CZK, with volume trending upward, suggesting increasing trader interest. Valuation metrics show a forward PE of 13.68 versus an industry average of 17.10, and a price‑to‑book of 1.68, indicating the stock is priced below peers on a value basis. A dividend yield of 8% is exceptionally high, but the payout ratio sits at 95.5%, raising questions about sustainability despite a sizable cash balance of 91.66 B CZK. The bank’s beta (≈0.12‑0.41) and 30‑day volatility (≈17%) point to low market sensitivity, while the max drawdown of ~13% reflects moderate downside risk. Overall, the combination of defensive fundamentals, attractive yield, and modest undervaluation supports a cautiously optimistic stance for longer horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price hovering just above the 1,111 CZK support level
- bearish MACD histogram indicating downward momentum
- RSI approaching oversold territory, limiting further downside
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- PE ratio well below the industry average, suggesting valuation upside
- high dividend yield offering attractive cash return
- stable cash position despite elevated debt levels
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- low beta and defensive profile suitable for a stable, income‑focused portfolio
- undervaluation relative to peers with upside potential above the 200‑day SMA
- consistent dividend payout providing long‑term income, despite current sustainability concerns
Key Metrics & Analysis
Financial Health
Revenue Growth-5.30%
Profit Margin47.09%
P/E Ratio11.8
ROE14.04%
ROA1.16%
P/B Ratio1.7
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI36.8
SupportCZK 1,111.00
ResistanceCZK 1,229.00
MA 20CZK 1,164.65
MA 50CZK 1,200.56
MA 200CZK 1,098.20
MACDBearish
VolumeIncreasing
Fear & Greed Index76.25
Valuation
Target PriceCZK 1,158.15
Upside/Downside2.58%
GradeUndervalued
TypeValue
Dividend Yield8.00%
Risk Assessment
Beta0.41
Volatility17.15%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.